Biocartis Group Stock Forward View - Simple Moving Average

BCART Stock  EUR 0.29  0.00  0.00%   
Biocartis Stock outlook is based on your current time horizon. Investors can use this forecasting interface to forecast Biocartis Group stock prices and determine the direction of Biocartis Group NV's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Biocartis Group's historical fundamentals, such as revenue growth or operating cash flow patterns.
As of today the value of rsi of Biocartis Group's share price is below 20 suggesting that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards.

Momentum 0

 Sell Peaked

 
Oversold
 
Overbought
The successful prediction of Biocartis Group's future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with Biocartis Group NV, which may create opportunities for some arbitrage if properly timed.
Using Biocartis Group hype-based prediction, you can estimate the value of Biocartis Group NV from the perspective of Biocartis Group response to recently generated media hype and the effects of current headlines on its competitors.
The Simple Moving Average forecasted value of Biocartis Group NV on the next trading day is expected to be 0.29 with a mean absolute deviation of 0.00 and the sum of the absolute errors of 0.00.

Biocartis Group after-hype prediction price

    
  EUR 0.29  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

Biocartis Group Additional Predictive Modules

Most predictive techniques to examine Biocartis price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Biocartis using various technical indicators. When you analyze Biocartis charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
A two period moving average forecast for Biocartis Group is based on an daily price series in which the stock price on a given day is replaced by the mean of that price and the preceding price. This model is best suited to price patterns experiencing average volatility.

Biocartis Group Simple Moving Average Price Forecast For the 31st of January

Given 90 days horizon, the Simple Moving Average forecasted value of Biocartis Group NV on the next trading day is expected to be 0.29 with a mean absolute deviation of 0.00, mean absolute percentage error of 0.00, and the sum of the absolute errors of 0.00.
Please note that although there have been many attempts to predict Biocartis Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Biocartis Group's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

Biocartis Group Stock Forecast Pattern

Backtest Biocartis Group  Biocartis Group Price Prediction  Buy or Sell Advice  

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the Simple Moving Average forecasting method's relative quality and the estimations of the prediction error of Biocartis Group stock data series using in forecasting. Note that when a statistical model is used to represent Biocartis Group stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information Criteria-9.223372036854776E14
BiasArithmetic mean of the errors None
MADMean absolute deviation0.0
MAPEMean absolute percentage error0.0
SAESum of the absolute errors0.0
The simple moving average model is conceptually a linear regression of the current value of Biocartis Group NV price series against current and previous (unobserved) value of Biocartis Group. In time series analysis, the simple moving-average model is a very common approach for modeling univariate price series models including forecasting prices into the future

Predictive Modules for Biocartis Group

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Biocartis Group NV. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Biocartis Group's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.290.290.29
Details
Intrinsic
Valuation
LowRealHigh
0.240.240.32
Details

Biocartis Group After-Hype Price Density Analysis

As far as predicting the price of Biocartis Group at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Biocartis Group or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Biocartis Group, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Biocartis Group Estimiated After-Hype Price Volatility

In the context of predicting Biocartis Group's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Biocartis Group's historical news coverage. Biocartis Group's after-hype downside and upside margins for the prediction period are 0.29 and 0.29, respectively. We have considered Biocartis Group's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
0.29
0.29
After-hype Price
0.29
Upside
Biocartis Group is very steady at this time. Analysis and calculation of next after-hype price of Biocartis Group NV is based on 3 months time horizon.

Biocartis Group Stock Price Outlook Analysis

Have you ever been surprised when a price of a Company such as Biocartis Group is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Biocartis Group backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Biocartis Group, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
 0.00  
0.00
 0.00  
 0.00  
0 Events / Month
0 Events / Month
In 5 to 10 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
0.29
0.29
0.00 
0.00  
Notes

Biocartis Group Hype Timeline

Biocartis Group NV is currently traded for 0.29on Euronext Brussels of Belgium. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Biocartis is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is currently at 0.0%. %. The volatility of related hype on Biocartis Group is about 0.0%, with the expected price after the next announcement by competition of 0.29. About 28.0% of the company shares are held by institutions such as insurance companies. The company recorded a loss per share of 1.24. Biocartis Group NV had not issued any dividends in recent years. The entity had 783:683 split on the . Assuming the 90 days trading horizon the next forecasted press release will be in 5 to 10 days.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

Biocartis Group Related Hype Analysis

Having access to credible news sources related to Biocartis Group's direct competition is more important than ever and may enhance your ability to predict Biocartis Group's future price movements. Getting to know how Biocartis Group's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Biocartis Group may potentially react to the hype associated with one of its peers.

Biocartis Group Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Biocartis Group stock to make a market-neutral strategy. Peer analysis of Biocartis Group could also be used in its relative valuation, which is a method of valuing Biocartis Group by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Biocartis Group Market Strength Events

Market strength indicators help investors to evaluate how Biocartis Group stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Biocartis Group shares will generate the highest return on investment. By undertsting and applying Biocartis Group stock market strength indicators, traders can identify Biocartis Group NV entry and exit signals to maximize returns.

Story Coverage note for Biocartis Group

The number of cover stories for Biocartis Group depends on current market conditions and Biocartis Group's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Biocartis Group is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Biocartis Group's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Other Macroaxis Stories

Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios

Biocartis Group Short Properties

Biocartis Group's future price predictability will typically decrease when Biocartis Group's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Biocartis Group NV often depends not only on the future outlook of the potential Biocartis Group's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Biocartis Group's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding79.9 M
Cash And Short Term Investments52.3 M

Other Information on Investing in Biocartis Stock

Biocartis Group financial ratios help investors to determine whether Biocartis Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Biocartis with respect to the benefits of owning Biocartis Group security.